Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressDividends payablesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (NHPAP) Liabilities and Shareholders Equity (2016 - 2025)

National Healthcare Properties (NHPAP) has 13 years of Liabilities and Shareholders Equity data on record, last reported at $1.7 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 12.04% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $5.3 billion, up 29.49%, while the annual FY2025 figure was $1.7 billion, 12.04% down from the prior year.
  • Liabilities and Shareholders Equity reached $1.7 billion in Q4 2025 per NHPAP's latest filing, down from $1.7 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.3 billion in Q1 2021 and bottomed at $1.7 billion in Q4 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $2.1 billion, with a median of $2.2 billion recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: decreased 0.02% in 2022, then dropped 14.15% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.2 billion in 2021, then decreased by 1.54% to $2.2 billion in 2022, then decreased by 1.61% to $2.1 billion in 2023, then fell by 9.28% to $1.9 billion in 2024, then fell by 12.04% to $1.7 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $1.7 billion in Q4 2025, $1.7 billion in Q3 2025, and $1.8 billion in Q1 2025.